12 results · 29ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EnCor Breast Biopsy Probe with Rinse Tube

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

RZ Medizintechnik GmbH

FDA UDI
RZ-Medizintechnik GmbH·04049197538299·Ikuta Bone Clamp 8 pointed theet jaw, fo rked s...

RZ Medizintechnik GmbH

FDA UDI
RZ-Medizintechnik GmbH·04049197538275·Ikuta Bone Clamp 8 pointed theet jaw, fo rked s...

RZ Medizintechnik GmbH

FDA UDI
RZ-Medizintechnik GmbH·04049197538305·Ikuta Bone Clamp 8 pointed theet jaw, fo rked s...

Rubicon SA System

FDA 510(k)
FDA Class 2 ·Anesthesiology

AT HOME DRUG TEST, MODEL 9078 T

FDA 510(k)
FDA Unclassified ·Unknown

QUADRA ASSURA CRT-D, DF-4 CONNECTOR

FDA Adverse Event
Injury ·ST. JUDE MEDICAL, INC., CRMD·Product code NIK·October 29, 2014

NEXGEN LPS FLEX ARTICULAR SURFACE

FDA Adverse Event
Injury ·ZIMMER, INC.·Product code JWH·August 10, 2011

RIATA ST ACTIVE FIXATION

FDA Adverse Event
Malfunction ·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code NVY·July 8, 2013

ACUSON S 1000, ACUSON S 2000, or ACUSON S 3000 ultrasound systems with software version C3, C3, C3, or C1. Model numbers: 10041461, 10440017  S 2000 system 10441730  S 3000 system 10441701  S 1000 system Radiology: The ultrasound imaging systems are intended for the following applications: Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Transcranial, OB/GYN, Cardiac, Pelvic, Neonatal/Adult Cephalic, Vascular, Musculoskeletal, Superficial Musculoskeletal, and Peripheral Vascular applications.

FDA Enforcement
Class II ·Terminated·Siemens Medical Solutions USA, Inc.·August 5, 2015

Model Number L211 PROPONENT DR SL MRI Pacemaker

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·October 22, 2025

PROPONENT DR Pacemaker, SL (Model Number L201), (VDD) SL (Model Number L209), SL MRI (Model Number L211), EL (Model Number L221), and EL MRI (Model Number L231).

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·January 22, 2025